Standout Papers
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study (2009)
- Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. (1996)
- Resistance Exercise in Men Receiving Androgen Deprivation Therapy for Prostate Cancer (2003)
Immediate Impact
4 by Nobel laureates 7 from Science/Nature 67 standout
Citing Papers
Renal Cell Carcinoma
2024 Standout
Renal cell carcinoma
2024 Standout
Works of Peter Venner being referenced
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
2009 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Peter Venner | 4734 | 3210 | 1747 | 1894 | 114 | 8.2k | |
| Brent A. Blumenstein | 5460 | 3852 | 3122 | 2782 | 121 | 11.7k | |
| Christopher L. Amling | 7435 | 2270 | 2017 | 1160 | 286 | 10.1k | |
| Francis J. McGovern | 4333 | 1553 | 1349 | 2599 | 89 | 6.4k | |
| Cary N. Robertson | 3034 | 2241 | 1311 | 1748 | 131 | 7.9k | |
| Alan Horwich | 5490 | 2585 | 2322 | 1926 | 136 | 10.1k | |
| Scott North | 5380 | 2710 | 1143 | 2507 | 192 | 7.4k | |
| Armen Aprikian | 4073 | 1947 | 2888 | 2141 | 279 | 8.4k | |
| Sergio Serni | 3008 | 1489 | 1366 | 1997 | 244 | 6.7k | |
| Jan‐Erik Johansson | 5498 | 1879 | 1880 | 805 | 101 | 7.9k | |
| Tobias Klatte | 5577 | 2047 | 2551 | 3817 | 275 | 8.6k |
All Works
Loading papers...